ロード中...
A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
BACKGROUND: Mucopolysaccharidosis type I (MPS I) is a genetic disease caused by the deficiency of α-L-iduronidase (IDUA) activity. MPS I is classified into three clinical phenotypes called Hurler, Scheie, and Hurler-Scheie syndromes according to their clinical severity. Treatments for MPS I are avai...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3849552/ https://ncbi.nlm.nih.gov/pubmed/24053568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-8-147 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|